Literature DB >> 34109994

Cell therapy and delivery strategies for spinal cord injury.

Bruna Dos S Ramalho1, Fernanda M de Almeida1,2, Ana M B Martinez3.   

Abstract

Spinal cord injury (SCI) is a complex neuropathological condition that represents a major challenge for clinicians and scientists due to patient's functional dysfunction and paralysis. Several treatments have been proposed including biological factors, drugs and cells administered in various ways. Stem cells arise as good candidates to treat SCI since they are known to secrete neurotrophic factors, improving neuroregeneration, but also due to their role in modulating the inflammatory process, favoring a pro-regenerative status. There are several types of cells that have been tested to treat SCI in experimental and clinical studies, but we still face many unanswered questions; one of them is the type of cells that can offer the best benefits and, also the ideal dose and administration routes. This review aimed to summarize recent research on cell treatment, focusing on current delivery strategies for SCI therapy and their effects in tissue repair and regeneration.

Entities:  

Mesh:

Year:  2021        PMID: 34109994     DOI: 10.14670/HH-18-350

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  127 in total

Review 1.  Secretome of Mesenchymal Stem Cells and Its Potential Protective Effects on Brain Pathologies.

Authors:  Eliana Baez-Jurado; Oscar Hidalgo-Lanussa; Biviana Barrera-Bailón; Amirhossein Sahebkar; Ghulam Md Ashraf; Valentina Echeverria; George E Barreto
Journal:  Mol Neurobiol       Date:  2019-04-02       Impact factor: 5.590

2.  Early Intravenous Delivery of Human Brain Stromal Cells Modulates Systemic Inflammation and Leads to Vasoprotection in Traumatic Spinal Cord Injury.

Authors:  Anna Badner; Reaz Vawda; Alex Laliberte; James Hong; Mirriam Mikhail; Alejandro Jose; Rachel Dragas; Michael Fehlings
Journal:  Stem Cells Transl Med       Date:  2016-05-31       Impact factor: 6.940

3.  Survival of neurally induced mesenchymal cells may determine degree of motor recovery in injured spinal cord rats.

Authors:  Arshak R Alexanian; Wai-Meng Kwok; Danijel Pravdic; Dennis J Maiman; Michael G Fehlings
Journal:  Restor Neurol Neurosci       Date:  2010       Impact factor: 2.406

4.  Mesenchymal stem cell transplantation reduces glial cyst and improves functional outcome after spinal cord compression.

Authors:  Marina Boido; Diego Garbossa; Marco Fontanella; Alessandro Ducati; Alessandro Vercelli
Journal:  World Neurosurg       Date:  2012-09-25       Impact factor: 2.104

5.  Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury.

Authors:  Qilin Cao; Qian He; Yaping Wang; Xiaoxin Cheng; Russell M Howard; Yiping Zhang; William H DeVries; Christopher B Shields; David S K Magnuson; Xiao-Ming Xu; Dong H Kim; Scott R Whittemore
Journal:  J Neurosci       Date:  2010-02-24       Impact factor: 6.167

6.  Transplanted neurally modified bone marrow-derived mesenchymal stem cells promote tissue protection and locomotor recovery in spinal cord injured rats.

Authors:  Arshak R Alexanian; Michael G Fehlings; Zhiying Zhang; Dennis J Maiman
Journal:  Neurorehabil Neural Repair       Date:  2011-08-15       Impact factor: 3.919

7.  Safety of Autologous Human Schwann Cell Transplantation in Subacute Thoracic Spinal Cord Injury.

Authors:  Kim D Anderson; James D Guest; W Dalton Dietrich; Mary Bartlett Bunge; Rosie Curiel; Marine Dididze; Barth A Green; Aisha Khan; Damien D Pearse; Efrat Saraf-Lavi; Eva Widerström-Noga; Patrick Wood; Allan D Levi
Journal:  J Neurotrauma       Date:  2017-03-21       Impact factor: 5.269

8.  [Intravenous infusion of adult adipose tissue stem cells for repairing spinal cord ischaemic lesions. An experimental study on animals].

Authors:  A Barriga; M Medrano; J De-Juan; J Burgos
Journal:  Rev Esp Cir Ortop Traumatol       Date:  2013-03-09

9.  Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury.

Authors:  M Birdsall Abrams; Cecilia Dominguez; Karin Pernold; Roxanne Reger; Zsuzsanna Wiesenfeld-Hallin; Lars Olson; Darwin Prockop
Journal:  Restor Neurol Neurosci       Date:  2009       Impact factor: 2.406

10.  Intraperitoneally infused human mesenchymal stem cells form aggregates with mouse immune cells and attach to peritoneal organs.

Authors:  Nikolay Bazhanov; Joni H Ylostalo; Thomas J Bartosh; April Tiblow; Arezoo Mohammadipoor; Andrea Foskett; Darwin J Prockop
Journal:  Stem Cell Res Ther       Date:  2016-02-10       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.